Microbiotica

Microbiotica is a clinical-stage biopharmaceutical company that develops live biotherapeutic products derived from microbiome science. The company utilizes a discovery platform to identify specific bacteria linked to patient outcomes to create co-therapies for immuno-oncology and inflammatory bowel disease. Its current pipeline includes treatments for advanced melanoma and ulcerative colitis.